"/> STEMCELL Technologies Ruxolitinib​ | B-LABO France

STEMCELL Technologies Ruxolitinib​

Réf. : BL-RE-126586Réf. fabricant : 17190212 1 mg
93,15 € HT

JAK/STAT pathway inhibitor; Inhibits JAK1 and JAK2

CAS
941678-49-5
Synonyme
INCB 018424, INC 424
Quantité
1 mg
Formule moléculaire
C17H18N6
Pureté
≥98%
Marque
STEMCELL Technologies

Caractéristiques principales

  • Ruxolitinib is an ATP mimic that inhibits all Janus-associated kinase (JAK) family kinases with a preference for JAK-1 and JAK-2 over JAK-3 and TYK2 with IC50 values of 3.3, 2.8, 428 and 19 nM respectively (Verstovsek; Quintás-Cardama et al.)
  • Suppresses erythroid progenitor colony formation from peripheral blood mononuclear cells of polycythemia vera patients with the constitutively active JAK2 V617F mutation
  • Reduces malignant cell proliferation and decreases interleukin-6 and TNF-α signaling in a JAK2 V617F-driven mouse model of myeloproliferative disorder (Quintás-Cardama et al.)
  • Promotes hair regrowth in a mouse model of alopecia areata (Xing et al.)

Caractéristiques techniques

MarqueSTEMCELL Technologies
Réf. B-LABOBL-RE-126586
Réf. fabricant17190212
CAS941678-49-5
SynonymeINCB 018424, INC 424
Quantité1 mg
Formule moléculaireC<sub>17</sub>H<sub>18</sub>N<sub>6</sub>
Pureté≥98%
Une question, une configuration particulière ?
Contactez-nous pour un devis.